EUVIMEDEUVIMED entdecken
Open Access

The NKCC1 Antagonist Bumetanide, Administered After Prenatal Alcohol Exposure, Mitigates Ethanol‐Induced Aberrance in Tangential Migration of GABAergic Interneurons in Mouse Medial Prefrontal Cortex

Betul Koc, Alexander G J Skorput, Pamela W L Yeh, Hermes H Yeh iD

Alcohol, Clinical and Experimental Research · 2026

DOI: 10.1111/acer.70375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, 2026. Verfasst von Betul Koc und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. Hauptthemen laut MEDLINE: Bumetanide, Prefrontal Cortex, Solute Carrier Family 12, Member 2, Ethanol. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prenatal ethanol (alcohol) exposure (PreEE) results in abnormal tangential migration of medial ganglionic eminence (MGE)‐derived GABAergic interneurons (GINs) in the embryonic mouse medial prefrontal cortex (mPFC); later in life, this is associated with impaired behavioral flexibility commonly seen in fetal alcohol spectrum disorders (FASD). The PreEE‐induced abnormal tangential migration involves, in part, ethanol potentiating GABA A receptor‐mediated depolarization, the latter due to elevated intracellular chloride sustained primarily by the Na‐K‐Cl cotransporter NKCC1 in embryonic GINs. We previously reported that coincident administration of the NKCC1 antagonist bumetanide with PreEE prevents the PreEE‐induced aberrant migration of GINs in the mPFC. However, such simultaneous dispensing rarely occurs in real life. In this light, the present study assessed whether bumetanide administered after PreEE mitigates the PreEE‐induced aberrant tangential migration.

Methods

NKCC1‐like immunofluorescence was assessed following immunohistochemical processing of 30‐μm cryosections derived from embryonic day (E)14.5 wild‐type mouse brains. Nkx2.1Cre‐Ai14 mice were used to genetically label MGE‐derived GINs. Pregnant dams were fed 5% ethanol (w/w) from E13.5 to E16.5, followed by bumetanide treatment (320 mg/kg liquid diet) from E17.5 until postnatal day (P) 0 (birth). Forty‐micron cryosections from brains of progeny were collected at P0, and the density as well as spatial distribution of tdTomato‐fluorescent (Nkx2.1+) GINs in the mPFC quantified.

Results

Within the timeframe of PreEE, the NKCC1 protein is expressed ubiquitously in the embryonic mouse brain, including the dorsomedial telencephalon, the precursor to mPFC. PreEE increased the overall density of Nkx2.1+ GINs and accelerated their dorsal‐to‐ventral dispersion across the developing mPFC. Post‐PreEE treatment with the NKCC1 antagonist bumetanide diminished these effects, reducing dorsal accumulation while preserving the baseline population of GINs.

Conclusions

These results indicate that blocking the NKCC1 chloride importer bumetanide can mitigate PreEE‐induced interneuronopathy when administered after PreEE, implicating NKCC1 as a potential pharmacological target for post‐PreEE therapeutic intervention of FASD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BumetanidePrefrontal CortexSolute Carrier Family 12, Member 2EthanolCell MovementPrenatal Exposure Delayed EffectsInterneuronsSodium Potassium Chloride Symporter InhibitorsGABAergic NeuronsAnimalsFemalePregnancyMiceMice, Inbred C57BL

Stichwörter der Autor:innen

FASDNKCC1 antagonist bumetanidemedial prefrontal cortexprenatal ethanol exposuretangential migration of cortical GABAergic interneurons

Substanzen

BumetanideSolute Carrier Family 12, Member 2EthanolSodium Potassium Chloride Symporter InhibitorsSlc12a2 protein, mouse

Autor:innen und Institutionen

  • Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Department of Neurology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.

ORCID-Profile: Hermes H Yeh

Förderung

  • NIAAA NIH HHS
  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Koc, B., Skorput, A. G. J., Yeh, P. W. L., & Yeh, H. H. (2026). The NKCC1 Antagonist Bumetanide, Administered After Prenatal Alcohol Exposure, Mitigates Ethanol‐Induced Aberrance in Tangential Migration of GABAergic Interneurons in Mouse Medial Prefrontal Cortex. Alcohol, Clinical and Experimental Research. https://doi.org/10.1111/acer.70375

Vancouver

Koc B, Skorput AGJ, Yeh PWL, Yeh HH. The NKCC1 Antagonist Bumetanide, Administered After Prenatal Alcohol Exposure, Mitigates Ethanol‐Induced Aberrance in Tangential Migration of GABAergic Interneurons in Mouse Medial Prefrontal Cortex. Alcohol, Clinical and Experimental Research. 2026. doi:10.1111/acer.70375

BibTeX
@article{Koc2026,
  author = {Koc, Betul and Skorput, Alexander G J and Yeh, Pamela W L and Yeh, Hermes H},
  title = {The NKCC1 Antagonist Bumetanide, Administered After Prenatal Alcohol Exposure, Mitigates Ethanol‐Induced Aberrance in Tangential Migration of GABAergic Interneurons in Mouse Medial Prefrontal Cortex},
  journal = {Alcohol, Clinical and Experimental Research},
  year = {2026},
  doi = {10.1111/acer.70375}
}
Kostenlos starten →